Amanote Research

Amanote Research

    RegisterSign In

Failure of Hypomethylating Agent–Based Therapy in Myelodysplastic Syndromes

Seminars in Oncology - United Kingdom
doi 10.1053/j.seminoncol.2011.04.011
Full Text
Open PDF
Abstract

Available in full text

Categories
OncologyHematology
Date

October 1, 2011

Authors
Tapan M. KadiaElias JabbourHagop Kantarjian
Publisher

Elsevier BV


Related search

The Myelodysplastic Syndromes: Diagnosis, Prognosis and Therapy

Italian Journal of Medicine
Medicine
2013English

Lenalidomide: Targeted Anemia Therapy for Myelodysplastic Syndromes

Cancer Control
MedicineOncologyHematology
2006English

Myelodysplastic Syndromes

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2011English

Myelodysplastic Syndromes

Cancer
Cancer ResearchOncology
2007English

Acute Myeloid Leukemia After Myelodysplastic Syndrome and Failure of Therapy With Hypomethylating Agents: An Emerging Entity With a Poor Prognosis

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2014English

Myelodysplastic Syndromes

2004English

Myelodysplastic Syndromes

2005English

Myelodysplastic Syndromes

2008English

Myelodysplastic Syndromes

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy